An Ever Growing Portfolio of Diverse Healthcare Companies

Develops needle-free, wireless, transdermal continuous glucose monitoring system

Develops antibody-based therapies to treat infectious diseases.

Develops and manufactures minimally invasive treatments for vascular diseases

Develops innovative device technology and treatment to address th eunmet needs of ENT physicians and their patients

Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care

Focuses on acquiring, developing and investing in products to translate innovative science into meaningful health care consumer brands

Provides reports and ratings to guide patients to better care providers

Manages radiology utlization with payer organization

Focuses on rapid development of prescription drugs for mild to moderate pain relief

Provides enterprise-level Web-based technologies for commercial, Medicare and Medicaid lines of business

Develops minimally-invasive hearing products

Rapidly identifies human DNA

Developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without injections

Provides financial solutions to health care facilities, including purchase of receivables and lien solutions programs

Develops a novel, non-invasive technology for the treatment of hypertension (HTN)

Develops and markets biologic products for the repair or replacement of damaged or inadequate tissues.

Develops a therapeutic platform that combines the best-in-class light activated drug and novel light generation devices to destroy tumors from the inside out

Develops proprietary technology for noninvasive cosmetic surgery applications

Provides centralized expert psychiatric rating and monitoring services to the pharmaceutical industry

Focuses on acquiring and developing novel, small-molecule therapeutics for the US market

Provider of online strategic patient engagement and analytics solutions for healthcare organizations

A leading Chinese developer of interventional medical products with life-saving solutions and treatments for patients

Develops medication management systems for the long-term care industry

Develops drug candidates targeting indications in ophthalmology, inflammation and oncology, with a lead DARPin in clinical Phase I/IIa